vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.

SolarMax Technology, Inc. is the larger business by last-quarter revenue ($46.6M vs $24.8M, roughly 1.9× Ceribell, Inc.). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -54.6%, a 52.7% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.

CBLL vs SMXT — Head-to-Head

Bigger by revenue
SMXT
SMXT
1.9× larger
SMXT
$46.6M
$24.8M
CBLL
Higher net margin
SMXT
SMXT
52.7% more per $
SMXT
-1.9%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
SMXT
SMXT
Revenue
$24.8M
$46.6M
Net Profit
$-13.5M
$-872.2K
Gross Margin
87.3%
2.7%
Operating Margin
-58.9%
-2.7%
Net Margin
-54.6%
-1.9%
Revenue YoY
623.5%
Net Profit YoY
77.7%
EPS (diluted)
$-0.35
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
SMXT
SMXT
Q4 25
$24.8M
$46.6M
Q3 25
$22.6M
$30.6M
Q2 25
$21.2M
$6.9M
Q1 25
$20.5M
$6.9M
Q4 24
$6.4M
Q3 24
$17.2M
$6.3M
Net Profit
CBLL
CBLL
SMXT
SMXT
Q4 25
$-13.5M
$-872.2K
Q3 25
$-13.5M
$-2.3M
Q2 25
$-13.6M
$-1.9M
Q1 25
$-12.8M
$-1.3M
Q4 24
$-3.9M
Q3 24
$-10.4M
$-9.6M
Gross Margin
CBLL
CBLL
SMXT
SMXT
Q4 25
87.3%
2.7%
Q3 25
88.3%
3.1%
Q2 25
88.1%
8.8%
Q1 25
87.9%
20.5%
Q4 24
14.5%
Q3 24
87.3%
19.9%
Operating Margin
CBLL
CBLL
SMXT
SMXT
Q4 25
-58.9%
-2.7%
Q3 25
-64.8%
-6.9%
Q2 25
-70.5%
-25.7%
Q1 25
-69.3%
-16.7%
Q4 24
-27.9%
Q3 24
-57.8%
-158.4%
Net Margin
CBLL
CBLL
SMXT
SMXT
Q4 25
-54.6%
-1.9%
Q3 25
-59.6%
-7.4%
Q2 25
-64.4%
-27.6%
Q1 25
-62.4%
-18.7%
Q4 24
-60.6%
Q3 24
-60.6%
-152.0%
EPS (diluted)
CBLL
CBLL
SMXT
SMXT
Q4 25
$-0.35
$-0.02
Q3 25
$-0.37
$-0.04
Q2 25
$-0.38
$-0.04
Q1 25
$-0.36
$-0.03
Q4 24
$-0.07
Q3 24
$-1.85
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
SMXT
SMXT
Cash + ST InvestmentsLiquidity on hand
$159.3M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$-12.2M
Total Assets
$195.8M
$91.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
SMXT
SMXT
Q4 25
$159.3M
$8.0M
Q3 25
$168.5M
$5.7M
Q2 25
$177.4M
$1.9M
Q1 25
$182.7M
$6.8M
Q4 24
$7.1M
Q3 24
$14.1M
$8.6M
Stockholders' Equity
CBLL
CBLL
SMXT
SMXT
Q4 25
$155.3M
$-12.2M
Q3 25
$164.1M
$-11.8M
Q2 25
$172.2M
$-15.1M
Q1 25
$180.9M
$-15.9M
Q4 24
$-15.1M
Q3 24
$-136.0M
$-10.9M
Total Assets
CBLL
CBLL
SMXT
SMXT
Q4 25
$195.8M
$91.3M
Q3 25
$199.5M
$58.7M
Q2 25
$207.7M
$38.2M
Q1 25
$213.5M
$38.6M
Q4 24
$38.6M
Q3 24
$47.1M
$43.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
SMXT
SMXT
Operating Cash FlowLast quarter
$-10.8M
$-2.5M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
SMXT
SMXT
Q4 25
$-10.8M
$-2.5M
Q3 25
$-11.1M
$3.4M
Q2 25
$-7.5M
$220.7K
Q1 25
$-11.4M
$-601.1K
Q4 24
$-1.3M
Q3 24
$203.6K
Free Cash Flow
CBLL
CBLL
SMXT
SMXT
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
Q1 25
$-11.6M
Q4 24
Q3 24
FCF Margin
CBLL
CBLL
SMXT
SMXT
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
Q1 25
-56.4%
Q4 24
Q3 24
Capex Intensity
CBLL
CBLL
SMXT
SMXT
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
Q1 25
0.7%
Q4 24
Q3 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

SMXT
SMXT

Yabucoa$35.9M77%
Other$10.7M23%

Related Comparisons